A naturally occurring peptide that may support healthy aging and cellular repair, according to Dr. Jason Schuster.
Klotho is a native protein that functions like a hormone, playing a central role in the body’s aging pathways. Dr. Jason Schuster highlights its emerging reputation as a powerful tool for tissue repair and longevity.
First identified in 1997, Klotho is produced from the Klotho gene on chromosome 13 and exists in several isoforms—including a transmembrane form dominant in the kidneys and a secreted form released in the brain and plasma. The peptide’s expression is boosted by aerobic exercise and naturally declines around age 40.
Dr. Schuster explains that Klotho modulates multiple longevity pathways, acting as a hormone‑like regulator of inflammation, oxidative stress, and metabolism. It interacts with the mTOR and Nrf2 pathways, helps regulate fibroblast growth factor‑23 (FGF23) and calcium homeostasis, and positively affects the ApoE gene linked to dementia risk.
According to the video, Klotho’s broad activity translates into a suite of protective effects across organ systems. It appears to limit chronic inflammation, reduce oxidative damage, and support mental and cardiovascular health, while also enhancing metabolic flexibility and muscle maintenance.
Human dosing has not been formally studied, but Dr. Schuster notes that animal trials—from mice to monkeys—show safety at 10 µg per kilogram of body weight with no lethal dose reported. Extremely high doses could alter FGF23 and calcium levels. The peptide is not patentable, which he argues limits formal clinical research and regulatory approval.
“Klotho is a natural, safe peptide that seems to alleviate age‑related decline across a huge array of diseases.”— Dr. Jason Schuster
Dr. Schuster's board-certified, accredited peptide therapy courses — the full research, dosing, and video breakdowns.